Potentiating therapeutic mAb-mediated CD16 activation of NK cells is an emerging area for cancer immunotherapy. CAR-NK cells with multi-specific molecules composed of stabilized CD16 and/or other ...

A new area of cancer immunotherapy is enhancing therapeutic mAb-mediated CD16 activation of NK cells. CAR-NK cells containing multi-specific molecules made up of relatively stable CD16 and other ...